Avanos Medical (AVNS) Treasury Shares (2015 - 2026)

Avanos Medical has disclosed Treasury Shares across 12 years of filings, most recently posting $103.6 million for Q1 2026.

• Treasury Shares for Q1 2026 came in at $103.6 million, up 2.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $103.6 million (up 2.37% YoY), and the FY2025 annual result was $102.3 million, up 3.33% from the prior year.
• Treasury Shares came in at $103.6 million for Q1 2026 at Avanos Medical, up from $102.3 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.7 million in Q4 2024 to a low of $342680.0 in Q1 2024.
• The 5-year median for Treasury Shares is $911433.0 (2022), against an average of $1.1 million.
• Across the five-year window, Treasury Shares soared 538.46% in 2022 and advanced 2.37% in 2026, its largest moves.
• Avanos Medical's Treasury Shares stood at $66.8 million in 2022, then climbed by 28.59% to $85.9 million in 2023, then gained by 15.25% to $99.0 million in 2024, then rose by 3.33% to $102.3 million in 2025, then climbed by 1.27% to $103.6 million in 2026.
• The last three Treasury Shares figures came in at $103.6 million (Q1 2026), $102.3 million (Q4 2025), and $102.0 million (Q3 2025), per Business Quant data.